Efficacy of Terpenoid in Attenuating Aortic Atherosclerosis in Apolipoprotein-E Deficient Mice: A Meta-Analysis of Animal Studies

BioMed Research International
Han LiuShuai Wang

Abstract

The apolipoprotein E knockout (ApoE -/-) mouse model is well established for the study of terpenoids in the prevention of atherosclerosis. Studies investigating the clinical benefit of terpenoids in humans are scarce. This systematic review and meta-analysis evaluated the effects of terpenoid administration on atherosclerotic lesion area in ApoE -/- mice. A comprehensive literature search using PubMed, Embase, and the Cochrane Library databases was performed to identify studies that assessed the effects of terpenoids on atherosclerosis in ApoE -/- mice. The primary outcome was atherosclerotic lesion area, and study quality was estimated using SYRCLE's risk of bias tool. The meta-analysis included 25 studies. Overall, terpenoids significantly reduced atherosclerotic lesion area when compared to vehicle control (P<0.00001; SMD: -0.55; 95% CI: -0.72, -0.39). In terpenoid type and dose subgroup analyses, sesquiterpenoid (P=0.002; SMD -0.93; 95% CI: -1.52, -0.34), diterpenoid (P=0.01; SMD: -0.30; 95% CI: -0.54, -0.06), triterpenoid (P<0.00001; SMD: -0.66; 95% CI: -0.94, -0.39), tetraterpenoid (P<0.0001; SMD: -1.81; 95% CI: -2.70, -0.91), low dose (P=0.0001; SMD: -0.51; 95% CI: -0.76, -0.25), medium dose (P<0.0001; SMD: -0.48; 95% CI...Continue Reading

References

Sep 13, 2005·Biochemical Pharmacology·Tom Hsun-Wei HuangBasil D Roufogalis
Feb 18, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Norifumi TakedaRyozo Nagai
Jun 3, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Oscar López-FrancoCarmen Gómez-Guerrero
Jun 2, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Susanne ZadelaarTeake Kooistra
Sep 17, 2009·Current Pharmaceutical Design·Victor M VictorAntonio Hernández-Mijares
Jan 23, 2010·The Journal of Nutritional Biochemistry·Amir J GuriJosep Bassaganya-Riera
Mar 15, 2011·Journal of Agricultural and Food Chemistry·Akiko KatsumataRyoji Nagai
Jul 2, 2011·European Heart Journal·Zhao-Jun YangUNKNOWN China National Diabetes and Metabolic Disorders Study Group
Oct 1, 2011·European Journal of Pharmacology·Niels Henrik BuusUlf Simonsen
Feb 15, 2012·Journal of Biomedical Science·Elisardo C VasquezSilvana S Meyrelles
Jun 9, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Suowen XuPeiqing Liu
Jun 6, 2013·Oxidative Medicine and Cellular Longevity·Patricia Fernández-RobredoAlfredo García-Layana
Jul 23, 2013·PLoS Medicine·C R Hooijmans, M Ritskes-Hoitinga
Mar 29, 2014·BMC Medical Research Methodology·Carlijn R HooijmansMiranda W Langendam
Apr 4, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xin LiuHui-Jun Yin
Nov 26, 2015·Biochemical and Biophysical Research Communications·Mengyang LiuYajun Duan
Jul 5, 2016·Acta Pharmacologica Sinica·Yu-Zhou GuiYi-Ping Wang
Jul 23, 2016·Nutrients·Sapir BechorAviv Shaish
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hua-Ting WangZu-Yi Yuan
Mar 30, 2017·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Lin XiaoPing Yao
Aug 26, 2017·Chemical Reviews·David W Christianson
Sep 26, 2017·Journal of Cellular and Molecular Medicine·Xue ZhangHui-Xia Lu
Oct 4, 2017·Lipids in Health and Disease·Adam Zmysłowski, Arkadiusz Szterk

❮ Previous
Next ❯

Software Mentioned

Adobe Photoshop
RevMan
Review Manager
SYRCLE

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.